AI Verdict
CVS has stronger fundamentals based on our AI analysis.
COR vs CVS Fundamental Comparison
| Metric | COR | CVS |
|---|---|---|
| Revenue | $164.3B | $100.4B |
| Net Income | $2.2B | $2.9B |
| Net Margin | 1.3% | 2.9% |
| ROE | 64.8% | 3.8% |
| ROA | 2.7% | 1.2% |
| Current Ratio | 0.95x | 0.87x |
| Debt/Equity | 3.65x | 0.78x |
| EPS | $11.27 | $2.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
COR vs CVS: Frequently Asked Questions
Is COR or CVS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), CVS has stronger fundamentals. COR is graded C (74% confidence) while CVS is graded C (75% confidence). This is not investment advice.
How does COR compare to CVS fundamentally?
Cencora, Inc. has ROE of 64.8% vs CVS HEALTH Corp's 3.8%. Net margins are 1.3% vs 2.9% respectively.
Which stock pays higher dividends, COR or CVS?
COR has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in COR or CVS for long term?
For long-term investing, consider that COR has a C grade with 74% confidence, while CVS has a C grade with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about COR vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For COR vs CVS, the AI consensus favors CVS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.